Fritextsökning
Innehållstyper
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Neurovive inleder fas II-studie
Första patienten rekryterad till studien Ciprics, på akut njurskada vid hjärtkirurgi.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
KI Innovations säljer projekt
Smartwise köper medtechprojektet Extroducer.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Hallå där Peter Wursé...
...ombudsman på Sveriges Läkarförbund, som håller på att starta en yrkesförening för läkare som arbetar i industrin. Varför då?
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Novo och Astra ligger bra till i internationell kraftmätning
Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.
-
Partnering offer for scientists and medics
For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
New type of stem cell discovered
The earlier view of the scientific community was that melanocytes, the pigment cells, derive from the spinal cord during the early fetal period and then move ov...
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Prisar politiker och Lundaforskare
Riksdagsledamoten Barbro Westerholm och professorn Catharina Svanborg får pris från Forska Sverige.
-
Definite answer with new cancerous gene
A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Vicore Pharma får tolv miljoner
Göteborgsbolaget får fem miljoner från Eurostars och ytterligare sju miljoner kronor från en tysk partner.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
BREAKING